Eurocrane(603966)
Search documents
法兰泰克(603966) - 关于2024年股票期权与限制性股票激励计划股票期权行权价格调整及部分股票期权注销完成的公告
2025-09-08 09:31
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 法兰泰克重工股份有限公司(以下简称"公司")于 2025 年 8 月 21 日召开 了公司第五届董事会第七次会议、第五届监事会第五次会议,审议通过了《关于 调整 2024 年股票期权与限制性股票激励计划相关事项的议案》《关于 2024 年股 票期权与限制性股票激励计划注销部分股票期权及回购注销部分限制性股票的 议案》,同意将公司 2024 年股票期权与限制性股票激励计划股票期权行权价格 由 6.43 元/股调整为 6.20 元/股;鉴于 4 名激励对象已离职,根据公司《2024 年 股票期权与限制性股票激励计划(草案)》及相关规定,取消该激励对象资格并 注销其已获授但尚未行权的股票期权共计 123,200 份。具体内容详见公司于 2025 年 8 月 22 日在上海证券交易所网站(www.sse.com.cn)披露的《关于 2024 年股票期权与限制性股票激励计划注销部分股票期权及回购注销部分限制性股 票的公告》(公告编号:2025-052)、《关于调整 2024 年股票期权与限 ...
法兰泰克(603966) - 关于公司董事辞任暨选举职工代表董事的公告
2025-09-08 09:30
(二) 离任对公司的影响 证券代码:603966 证券简称:法兰泰克 公告编号:2025-061 法兰泰克重工股份有限公司 关于公司董事辞任暨选举职工代表董事的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、董事离任情况 (一) 提前离任的基本情况 | 姓名 | 离任职务 | 离任时间 | | | 原定任期 | | | 离任原因 | 是否继续在上 市公司及其控 | 具体职务 | 是否存在 未履行完 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | 到期日 | | | | 股子公司任职 | (如适用) | 毕的公开 | | | | | | | | | | | | | 承诺 | | 徐珽 | 董事 | 2025 | 年 | 9 | 2027 年 | 5 | 月 | 公司内部 | 是 | 行业销售 | 否 | | | | 月 5 | 日 | | 16 日 | | | 工作调整 | | 总监 | | ...
法兰泰克(603966) - 关于法兰泰克2025年第一次临时股东大会法律意见书
2025-09-08 09:30
2025 年第一次临时股东大会的 法律意见书 致:法兰泰克重工股份有限公司 根据《中华人民共和国公司法》《中华人民共和国证券法》等相关法律、法 规和规范性文件及《法兰泰克重工股份有限公司章程》(以下简称"公司章程") 之规定,北京市中伦律师事务所(以下简称"本所")接受法兰泰克重工股份有 限公司(以下简称"公司")委托,对公司 2025 年第一次临时股东大会(以下 简称"本次股东大会")相关事项进行了见证,并在此基础上出具本法律意见书。 本法律意见书仅供公司本次股东大会之目的使用,本所律师同意将本法律意 见书随同公司本次股东大会决议及其他信息披露资料一并公告。 为出具本法律意见书,本所律师审查了公司提供的相关文件资料,听取了公 司就有关事实所作的陈述和说明,并进行了必要的验证,现就本次股东大会的有 关法律事项出具法律意见如下: 一、本次股东大会的召集与召开程序 本次股东大会由公司董事会召集。公司董事会已于 2025 年 8 月 22 日公告了 召开本次股东大会的通知。上述通知载明了本次股东大会的召开时间、召开方式、 股权登记日、出席对象、现场会议召开地点、审议的议案、现场会议登记方法、 北京市中伦律师事务所 ...
法兰泰克(603966) - 2025年第一次临时股东大会决议公告
2025-09-08 09:30
证券代码:603966 证券简称:法兰泰克 公告编号:2025-060 法兰泰克重工股份有限公司 2025年第一次临时股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 本次会议是否有否决议案:无 一、 会议召开和出席情况 (四)表决方式是否符合《公司法》及《公司章程》的规定,大会主持情况等。 公司董事长、副董事长因工作原因不能主持本次会议,经过半数董事推举公 司董事王文艺先生主持本次股东大会现场会议。会议的表决方式符合《公司法》 及《公司章程》的规定。 (一)股东大会召开的时间:2025 年 9 月 8 日 (二)股东大会召开的地点:江苏省吴江汾湖经济开发区汾越路 288 号公司会议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况: | 1、出席会议的股东和代理人人数 | 405 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数(股) | 147,900,986 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | 37.0957 | ...
法兰泰克: 2025年第一次临时股东大会资料
Zheng Quan Zhi Xing· 2025-09-01 16:10
Group 1 - The company will hold its first extraordinary general meeting of shareholders in 2025 on September 3, with the meeting organized to ensure order and efficiency [1][2] - The meeting will combine on-site voting and online voting, with specific time slots for each voting method [2] - The location for the on-site meeting is set at the company's conference room in Jiangsu Province [2] Group 2 - The company proposes to cancel the supervisory board and transfer its powers to the audit committee of the board of directors, in accordance with relevant laws and regulations [3] - The company plans to increase its registered capital, with the total share capital expected to rise to 398,700,736 shares and registered capital to 398,700,736 yuan [5] - The company will revise its articles of association, with significant changes outlined in a detailed disclosure [5][7] Group 3 - The company will also revise certain management systems in accordance with the Company Law and Securities Law [7] - Specific details regarding the management system revisions will be published on August 22, 2025 [7]
法兰泰克(603966) - 2025年第一次临时股东大会资料
2025-09-01 08:30
法兰泰克重工股份有限公司 2025年第一次临时股东大会资料 (603966) 2025 年 9 月 | 2025 | 年第一次临时股东大会须知 1 | | --- | --- | | 2025 年第一次临时股东大会议程 | 3 | | 关于取消监事会、增加注册资本及修订《公司章程》并办理工商变更登记的议案 | 5 | | 关于修订公司部分管理制度的议案 8 | | 2025 年第一次临时股东大会须知 法兰泰克重工股份有限公司 2025 年第一次临时股东大会须知 为了维护全体股东的合法权益,确保法兰泰克重工股份有限公司(以下简称 "法兰泰克"或"公司")2025年第一次临时股东大会的正常秩序和议事效率, 根据《公司法》、《上海证券交易所股票上市规则》等相关规定,制定本须知。 一、股东大会会议组织 1、本次股东大会由公司董事会依法召集。 2、本次股东大会行使《公司法》和《公司章程》规定的股东大会职权。 3、公司董事会办公室具体负责会议组织、相关事务处理等事宜。 4、本次股东大会设计票人两名、监票人两名。 5、出席本次股东大会的人员 (1)2025年9月3日15:00收市后在中国证券登记结算有限公司上海分公司登 记 ...
法兰泰克涨2.35%,成交额1.62亿元,主力资金净流入1677.06万元
Xin Lang Cai Jing· 2025-09-01 05:21
Company Overview - FalanTech is primarily engaged in the research, manufacturing, and sales of mid-to-high-end bridges, gantry cranes, electric hoists, and construction machinery components, with 93.72% of its revenue coming from material handling equipment and services [1][2] - The company was established on June 19, 2007, and went public on January 25, 2017 [1] Financial Performance - For the first half of 2025, FalanTech reported a revenue of 1.182 billion yuan, representing a year-on-year growth of 46.63%, and a net profit attributable to shareholders of 122 million yuan, up 41.05% year-on-year [2] - The company has distributed a total of 449 million yuan in dividends since its A-share listing, with 252 million yuan distributed over the past three years [3] Stock Performance - As of September 1, FalanTech's stock price increased by 2.35% to 11.75 yuan per share, with a total market capitalization of 4.685 billion yuan [1] - The stock has seen a year-to-date increase of 56.88%, with a 2.09% rise over the last five trading days, 9.00% over the last 20 days, and 24.21% over the last 60 days [1] Shareholder Structure - As of June 30, 2025, FalanTech had 17,900 shareholders, a decrease of 1.22% from the previous period, with an average of 22,265 circulating shares per shareholder, an increase of 12.25% [2][3] - New institutional shareholders include Hua'an Ankang Flexible Allocation Mixed A and Huaxia Double Bond Bond A, among others, which have entered the top ten circulating shareholders [3] Market Position - FalanTech operates within the machinery equipment sector, specifically in specialized equipment for energy and heavy machinery, and is involved in various concept sectors including hydropower, western development, and the Belt and Road Initiative [2]
法兰泰克(603966):Q2实现高增 布局下游进入增长期 看好公司业绩增长
Xin Lang Cai Jing· 2025-08-25 00:36
Core Viewpoint - The company has demonstrated strong revenue and profit growth in Q2 2025, indicating enhanced market expansion capabilities and a positive outlook for continued performance growth [1][3]. Group 1: Financial Performance - In Q2 2025, the company achieved revenue of 774 million yuan, a year-on-year increase of 67.7%, and a net profit attributable to shareholders of 88 million yuan, up 42.1% year-on-year [1]. - The company has revised its profit forecasts for 2025-2027, expecting net profits of 265 million yuan, 352 million yuan, and 431 million yuan respectively, up from previous estimates [3]. Group 2: Market Expansion - The company has made significant breakthroughs in the shipbuilding industry, with new orders reaching a historical high for the same period, driven by ongoing investments in China's transportation equipment manufacturing sector [1]. - The company has established a strong international presence, with overseas revenue of 373 million yuan in the first half of the year, a year-on-year increase of 39.79%, accounting for 31.52% of total revenue [2]. Group 3: Industry Trends - The ongoing investment in hydropower projects in China is expected to support long-term growth for the company, particularly in the crane demand sector [2]. - The company’s subsidiary, Guodian Dali, is positioned as a leader in the hydropower construction field, focusing on technological innovation, with new orders significantly exceeding last year's total [2].
法兰泰克2025年中报简析:营收净利润同比双双增长,公司应收账款体量较大
Zheng Quan Zhi Xing· 2025-08-22 22:17
Core Viewpoint - The financial performance of Falan Tech (603966) for the first half of 2025 shows significant growth in revenue and net profit, indicating strong operational performance despite some declines in profit margins [1][6]. Financial Performance Summary - Total revenue for the first half of 2025 reached 1.182 billion yuan, a year-on-year increase of 46.63% compared to 806 million yuan in 2024 [1]. - Net profit attributable to shareholders was 122 million yuan, up 41.05% from 86.58 million yuan in the previous year [1]. - The second quarter alone saw total revenue of 774 million yuan, reflecting a 67.67% increase year-on-year [1]. - The gross profit margin decreased to 24.06%, down 21.37% from the previous year, while the net profit margin also fell to 10.49%, a decrease of 4.77% [1]. - The company reported a significant increase in operating cash flow per share, which rose to 0.65 yuan, a staggering increase of 1137.24% year-on-year [1]. Balance Sheet Highlights - Cash and cash equivalents increased by 68.82% to 638 million yuan, attributed to improved accounts receivable collections [3]. - Accounts receivable decreased by 4.83% to 588 million yuan, but still represented 352.4% of net profit, indicating a high level of receivables relative to profit [1][7]. - Interest-bearing debt saw a significant reduction of 60.44%, down to 251 million yuan, primarily due to repayment of loans [5]. - The company’s total liabilities decreased, with long-term borrowings down by 32.28% due to loan repayments [5]. Operational Insights - The increase in revenue was driven by a sustained rise in main business orders and smooth project acceptance and delivery [6]. - The company’s return on invested capital (ROIC) was reported at 8.74%, with a historical median of 10.47%, indicating a generally stable investment return profile [6]. Fund Holdings - Notable funds holding Falan Tech shares include Huaxia Double Bond Fund A, which has recently entered the top ten holdings with 2.1285 million shares [8]. - The largest fund, Huaxia Double Bond Fund A, has a scale of 1.55 billion yuan and has seen a 29.19% increase in value over the past year [8].
8月22日晚间重要公告一览
Xi Niu Cai Jing· 2025-08-22 10:13
Group 1 - Gujia Home achieved a net profit of 1.02 billion yuan in the first half of 2025, a year-on-year increase of 13.89% [1] - Gujia Home's revenue for the first half of 2025 was 9.80 billion yuan, up 10.02% year-on-year [1] - Phoenix Holdings reported a net profit of 11.04 million yuan, successfully turning a profit [1] - Phoenix Holdings' revenue increased by 200.78% year-on-year to 291 million yuan [1] - Zheshang Securities recorded a net profit of 1.15 billion yuan, a year-on-year growth of 46.49% [1] - Zheshang Securities' revenue decreased by 23.66% to 6.11 billion yuan [1] Group 2 - Tianjin Port's net profit was 503 million yuan, a year-on-year decrease of 18.33% [3] - Tianjin Port's revenue for the first half of 2025 was 6.18 billion yuan, an increase of 4.33% year-on-year [3] - Xuantai Pharmaceutical reported a net profit of 45.59 million yuan, down 15.82% year-on-year [5] - Xuantai Pharmaceutical's revenue was 220 million yuan, a slight increase of 0.74% year-on-year [5] Group 3 - Yilida achieved a net profit of 40.03 million yuan, a year-on-year increase of 18.32% [7] - Yilida's revenue for the first half of 2025 was 758 million yuan, up 12.56% year-on-year [7] - Zhongji United reported a net profit of 262 million yuan, a significant year-on-year increase of 86.61% [9] - Zhongji United's revenue was 818 million yuan, a year-on-year growth of 43.52% [9] Group 4 - China Shipbuilding Special Gas reported a net profit of 178 million yuan, a slight decrease of 0.55% year-on-year [10] - China Shipbuilding Special Gas' revenue was 1.04 billion yuan, an increase of 12.60% year-on-year [10] - Xinyuan Intelligent Manufacturing achieved a net profit of 9.79 million yuan, a year-on-year increase of 284.45% [11] - Xinyuan Intelligent Manufacturing's revenue was 329 million yuan, up 388.33% year-on-year [11] Group 5 - Jiudian Pharmaceutical reported a net profit of 291 million yuan, a year-on-year increase of 2.57% [13] - Jiudian Pharmaceutical's revenue was 1.51 billion yuan, a year-on-year growth of 10.67% [13] - Boya Biological reported a net profit of 225 million yuan, down 28.68% year-on-year [15] - Boya Biological's revenue was 1.01 billion yuan, an increase of 12.51% year-on-year [15] Group 6 - True Love Home achieved a net profit of 197 million yuan, a year-on-year increase of 484.48% [17] - True Love Home's revenue was 390 million yuan, up 21.82% year-on-year [17] - Dongfang Electronics reported a net profit of 302 million yuan, a year-on-year increase of 19.65% [19] - Dongfang Electronics' revenue was 3.16 billion yuan, a year-on-year growth of 12.18% [19] Group 7 - Watte Holdings achieved a net profit of 18.41 million yuan, a year-on-year increase of 23.94% [21] - Watte Holdings' revenue was 906 million yuan, up 12.29% year-on-year [21] - Tianqin Equipment reported a net profit of 16.36 million yuan, a year-on-year increase of 2.78% [22] - Tianqin Equipment's revenue was 111 million yuan, a year-on-year growth of 18.42% [22] Group 8 - Yingfeng Environment achieved a net profit of 382 million yuan, a year-on-year increase of 0.43% [24] - Yingfeng Environment's revenue was 6.46 billion yuan, up 3.69% year-on-year [24] - Kexin Machinery reported a net profit of 52.20 million yuan, a year-on-year decrease of 46.18% [26] - Kexin Machinery's revenue was 592 million yuan, down 17.26% year-on-year [26] Group 9 - Tengda Construction reported a net profit of 108 million yuan, a year-on-year decrease of 0.69% [27] - Tengda Construction's revenue was 1.61 billion yuan, down 5.20% year-on-year [27] - Canaan Technology achieved a net profit of 7.35 million yuan, a year-on-year decrease of 38.46% [29] - Canaan Technology's revenue was 560 million yuan, up 1.29% year-on-year [29] Group 10 - Metro Design reported a net profit of 221 million yuan, a year-on-year increase of 6.58% [30] - Metro Design's revenue was 1.32 billion yuan, up 5.31% year-on-year [30] - China Shipbuilding Special Gas plans to use up to 2.9 billion yuan of idle funds for cash management [31] - The company intends to invest in safe, liquid, principal-protected products [31] Group 11 - Jiuchuang Biotechnology received a medical device registration certificate for its lupus anticoagulant detection kit [32] - The product is intended for in vitro qualitative detection of lupus anticoagulant in human plasma [32] - Xinowei's subsidiary received approval for clinical trials of its innovative drug [33] - The drug is a humanized monoclonal antibody intended for treating multiple cancers [33] Group 12 - Dongcheng Pharmaceutical's subsidiary received FDA approval for clinical trials of its targeted radiopharmaceutical [34] - The drug is intended for treating advanced prostate cancer [34] - Shandong Road and Bridge received approval to issue bonds up to 4 billion yuan [35] - The company specializes in road and bridge engineering construction [35] Group 13 - Diou Home plans to invest 500 million yuan to establish a subsidiary focused on generative AI [36] - The investment aims to transform the company into a full-stack industrial intelligent service provider [36] - Dayilong achieved a net profit of 90.87 million yuan, a year-on-year increase of 217.89% [37] - Dayilong's revenue was 957 million yuan, up 57.35% year-on-year [37] Group 14 - Chaohongji reported a net profit of 331 million yuan, a year-on-year increase of 44.34% [38] - Chaohongji's revenue was 4.10 billion yuan, up 19.54% year-on-year [38] - Taiji Group reported a net profit of 139 million yuan, a year-on-year decrease of 71.94% [39] - Taiji Group's revenue was 5.66 billion yuan, down 27.63% year-on-year [39] Group 15 - Suneng Co. reported a net profit of 93.19 million yuan, a year-on-year decrease of 90.13% [41] - Suneng Co.'s revenue was 5.57 billion yuan, down 17.15% year-on-year [41] - Three Gorges Water Conservancy reported a net profit of 47.93 million yuan, a year-on-year decrease of 79.07% [42] - Three Gorges Water Conservancy's revenue was 4.90 billion yuan, down 6.10% year-on-year [42] Group 16 - Furida reported a net profit of 108 million yuan, a year-on-year decrease of 15.16% [44] - Furida's revenue was 1.79 billion yuan, down 7.05% year-on-year [44] - Chenzhou Electric International achieved a net profit of 25.92 million yuan, a year-on-year increase of 29.55% [46] - Chenzhou Electric International's revenue was 1.96 billion yuan, up 1.26% year-on-year [46] Group 17 - Farlantek achieved a net profit of 122 million yuan, a year-on-year increase of 41.05% [47] - Farlantek's revenue was 1.18 billion yuan, up 46.63% year-on-year [47] - Huitai Medical reported a net profit of 425 million yuan, a year-on-year increase of 24.11% [48] - Huitai Medical's revenue was 1.21 billion yuan, up 21.26% year-on-year [48] Group 18 - Dameng Data's director is under investigation for suspected violations [49] - The company's daily operations remain normal [49] - Maiwei Co. reported a net profit of 394 million yuan, a year-on-year decrease of 14.59% [50] - Maiwei Co.'s revenue was 4.21 billion yuan, down 13.48% year-on-year [50] Group 19 - Waiservice Holdings achieved a net profit of 384 million yuan, a year-on-year increase of 5.51% [52] - Waiservice Holdings' revenue was 12.25 billion yuan, up 16.15% year-on-year [52] - Huakang Co. reported a net profit of 134 million yuan, a year-on-year decrease of 3.38% [53] - Huakang Co.'s revenue was 1.87 billion yuan, up 37.32% year-on-year [53] Group 20 - Bluelight Optical achieved a net profit of 103 million yuan, a year-on-year increase of 110.27% [54] - Bluelight Optical's revenue was 577 million yuan, up 52.54% year-on-year [54] - Shunwang Technology reported a net profit of 162 million yuan, a year-on-year increase of 69.22% [55] - Shunwang Technology's revenue was 1.01 billion yuan, up 25.09% year-on-year [55] Group 21 - Anbiping reported a net loss of 12.50 million yuan in the first half of 2025 [56] - Anbiping's revenue was 159 million yuan, down 30.11% year-on-year [56] - Jinhua Co. reported a net profit of 6.20 million yuan, a year-on-year decrease of 34.53% [57] - Jinhua Co.'s revenue was 241 million yuan, down 1.90% year-on-year [57] Group 22 - Xiehe Electronics achieved a net profit of 28.96 million yuan, a year-on-year decrease of 8.31% [59] - Xiehe Electronics' revenue was 451 million yuan, up 12.13% year-on-year [59] - Huguang Co. reported a net profit of 276 million yuan, a year-on-year increase of 8.40% [60] - Huguang Co.'s revenue was 3.63 billion yuan, up 6.20% year-on-year [60]